leadf
logo-loader
AIM:ODX

Omega Diagnostics Group PLC

Receive alerts
Market:
AIM
Market Cap:
£162.64 m
Price
89.25 GBX
Change
-0.83%
52 weeks high
127.00
52 weeks low
5.93

In brief

Omega Diagnostics Group PLC is a United Kingdom-based holding company. The Company, along with its subsidiaries, is principally engaged in the manufacture, development and distribution of medical diagnostic products. On September 3, 2007, the Company acquired 100% of the voting shares of Genesis Diagnostics Ltd (Genesis) and Cambridge Nutritional Sciences Ltd (CNS). Genesis operates in the medical diagnostics industry developing, producing and selling a range of test kits specializing in the areas of autoimmune disease, infectious diseases and food intolerance. CNS provides a testing service for food intolerance and various other diseases.